Order Article Reprints

Pereira-Vieira J, Weber DD, Silva S, Barbosa-Matos C, Granja S, Reis RM, Queirós O, Ko YH, Kofler B, Casal M, et al. Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia. Pharmaceutics. 2024; 16(4):442. https://doi.org/10.3390/pharmaceutics16040442

Pereira-Vieira, Joana, Daniela D. Weber, Sâmia Silva, Catarina Barbosa-Matos, Sara Granja, Rui Manuel Reis, Odília Queirós, Young H. Ko, Barbara Kofler, Margarida Casal, and et al. 2024. "Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia" Pharmaceutics 16, no. 4: 442. https://doi.org/10.3390/pharmaceutics16040442

Pereira-Vieira, J., Weber, D. D., Silva, S., Barbosa-Matos, C., Granja, S., Reis, R. M., Queirós, O., Ko, Y. H., Kofler, B., Casal, M., & Baltazar, F. (2024). Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia. Pharmaceutics, 16(4), 442. https://doi.org/10.3390/pharmaceutics16040442